logo

For the Inventor, By the Inventor

Otsu, Japan

Hiromu Murai

This inventor holds 17 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignees: Nippon Shinyaku Company, Ltd., Takara Shuzo Co., Inc., Other. Active years: 1976-1980.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiromu Murai. Retrieved from https://idiyas.com/inventor/hiromu-murai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 17

% Patents Active = 100.0

Average Co-Inventor Count = 5.9

ph-index = 5

Forward Citations = 146(Granted Patents)


Location History:

  • Otsu, JA (1977)
  • Minami Kyoto, JA (1977)
  • Kyoto, JA (1976 - 1978)
  • Otsu, JP (1978 - 1980)
  • Kyoto, JP (1979 - 1980)

Company Filing History:

goldMedal15 out of 229 
 
Nippon Shinyaku Company, Ltd.
 patents
silverMedal1 out of 190 
 
Takara Shuzo Co., Inc.
 patents
bronzeMedal2 out of 834,601 
Other
 patents
where one patent can have more than one assignee

Years Active: 1976-1980

Loading Chart...
Areas of Expertise:
Morpholinone Derivatives
Abietamide Derivatives
Antihyperglycemic Compounds
Piperidine Methanol
Carboxymethyl Derivatives
Dihydropimaramide Derivatives
Benzylpicolinic Acid
Nicotinamido-s-triazines
Steryl-.beta.-D-glucoside Esters
Pharmaceutical Compositions
Benzoguanamine Derivatives
Abietanilides
17 patents (USPTO):Explore Patents
1. 4237132 - Morpholinone derivatives and method of use (1980-12-02),
2. 4210671 - Abietamide derivatives, their production and use (1980-07-01),
3. 4182767 - Antihyperglycemic N-alkyl-3,4,5-trihydroxy-2-piperidine methanol (1980-01-08),
4. 4162331 - Substituted N-(carboxymethyl)-3-aminopropan-2-ol derivatives (1979-07-24),
5. 4137231 - Process for the isolation of 2-hydroxymethyl-3,4,5-trihydroxypiperidine (1979-01-30),
6. 4117159 - Pharmaceutically active deltab-dihydropimaramide derivatives (1978-09-26),
7. 4109000 - 5-Benzylpicolinic acid derivatives (1978-08-22),
8. 4103009 - Benzoguanamine derivatives (1978-07-25),
9. 4100285 - N-substituted trialkoxybenzyl piperazine derivatives (1978-07-11),
10. 4098892 - Nicotinamido-s-triazines (1978-07-04),
11. 4094991 - Substituted N-(carboxymethyl)-3-aminopropan-2-ol derivatives (1978-06-13),
12. 4064252 - Substituted N-(carboxymethyl)-3-aminopropan-2-ol derivatives (1977-12-20),
13. 4031303 - Steryl-.beta.-D-glucoside esters and method of preparation (1977-06-21),
14. 4024280 - Abietanilides, their production and use (1977-05-17),
15. 4009206 - N-(substituted phenyl and benzyl)abietamides (1977-02-22),

Title: Hiromu Murai: Innovator in Morpholinone and Abietamide Derivatives

Introduction

Hiromu Murai is a prominent inventor located in Otsu, Japan, whose innovative contributions are reflected in his 17 patents. His research predominantly focuses on developing novel compounds with potential therapeutic applications, particularly in drug development for cardiovascular conditions.

Latest Patents

Among Hiromu Murai's latest patented inventions are the "Morpholinone derivatives and method of use." This patent outlines the preparation of new 4,6-disubstituted 2-morpholinone derivatives through a unique reaction involving epoxide derivatives and phenylglycine derivatives, or by utilizing isopropanol derivatives with carboxylic acid derivatives. These new morpholinone derivatives show promise for the prevention and treatment of arteriosclerosis. Additionally, he has authored a patent entitled "Abietamide derivatives, their production and use," which describes a method for synthesizing amide derivatives from abietic acid and its various forms by reacting with specific amines, contributing to the field of organic chemistry.

Career Highlights

Throughout his career, Hiromu Murai has held positions at notable organizations, including Nippon Shinyaku Company, Ltd., where he developed essential compounds that have medical implications. His extensive work in the pharmaceutical field has solidified his reputation as an innovative inventor with a keen focus on the development of new therapeutic agents.

Collaborations

Murai has collaborated with esteemed professionals in his field, including Hiroshi Enomoto and Katsuya Ohata. These partnerships have facilitated significant advancements in his research, allowing for a synergy of ideas and expertise in developing new compounds.

Conclusion

Hiromu Murai's contributions to the field of medicinal chemistry through his inventions of morpholinone and abietamide derivatives highlight his commitment to addressing critical health challenges. His work exemplifies the spirit of innovation that drives progress in pharmaceutical developments. As an inventor with numerous patents, he continues to impact the scientific community positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…